Ascendis Pharma A/S at Bank of America Merrill Lynch Health Care Conference Transcript
The senior biotech analyst here at Bank of America Merrill Lynch. It's our pleasure to introduce Ascendis this morning. Speaking for Ascendis, sitting next to me, is Jan Mikkelsen, Chief Executive Officer; and sitting next to him is Scott Smith, Chief Financial Officer and Chief Strategist of the company.
This will be a Q&A session. Feel free to ask any questions that you might have. And maybe we can kick it off, Jan, with the recent data that you presented for growth hormone deficiency. So if you can give us a 2-minute summary of Ascendis and what's happening and maybe start off by focusing on GHD and then we can go from there.
¸ - /- -
First, thanks a lot, Tazeen. It's a pleasure to be here. And also this is one of the first opportunities we have really to go out to a conference after our Phase III heiGHt data. So it's fair
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
